- Home
- DTIL vs GHI Comparison
DTIL vs GHI Comparison
Compare DTIL & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DTIL | GHI |
|---|---|---|
| Founded | 2006 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.3M | 173.3M |
| IPO Year | 2019 | 1998 |
Fundamental Metrics
Financial Performance| Metric | DTIL | GHI |
|---|---|---|
| Price | $6.43 | $5.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $45.00 | $10.50 |
| AVG Volume (30 Days) | ★ 350.0K | 50.6K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 22.93% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | ★ $1,070,000,000.00 | $85,389,766.00 |
| Revenue This Year | N/A | $273.95 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $516.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.53 | $4.71 |
| 52 Week High | $8.82 | $12.27 |
Technical Indicators
Market Signals| Indicator | DTIL | GHI |
|---|---|---|
| Relative Strength Index (RSI) | 44.17 | 43.74 |
| Support Level | $6.39 | $5.04 |
| Resistance Level | $8.12 | $5.52 |
| Average True Range (ATR) | 0.66 | 0.13 |
| MACD | -0.07 | -0.01 |
| Stochastic Oscillator | 20.72 | 23.92 |
Price Performance
Historical ComparisonAbout DTIL Precision BioSciences Inc.
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.